Latest market price
144.85
+0.51+0.35%
OverviewShort InterestFilings
PTGXQT66Protagonist Therapeutics, Inc.·NASDAQ
144.85+0.35%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 02, 20264Statement of changes in beneficial ownership
Sep 10, 20264Statement of changes in beneficial ownership
Sep 08, 20264Statement of changes in beneficial ownership
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 12, 20264Statement of changes in beneficial ownership
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 05, 2026S-8 POSS-8 POS
Aug 05, 2026S-8 POSS-8 POS
Aug 05, 2026S-8 POSS-8 POS
Aug 05, 2026S-8 POSS-8 POS
Aug 05, 20268-KCurrent report
Aug 05, 2026S-8 POSS-8 POS
Aug 05, 2026S-8 POSS-8 POS
Aug 05, 2026S-8 POSS-8 POS
Aug 05, 2026S-8 POSS-8 POS
Aug 05, 2026S-8 POSS-8 POS
Aug 05, 2026S-8 POSS-8 POS
Aug 05, 2026S-8Registration of employee benefit securities
Aug 05, 202610-QQuarterly report
Aug 05, 2026S-8 POSS-8 POS
Jun 25, 20264Statement of changes in beneficial ownership
Jun 18, 20268-KCurrent report
Jun 11, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
#1 / 25 of 310
Page
▼
/ 13